Regulatory 2021-11-04 | Quarterly Report Q3 2021: Oncoral – entering clinical collaboration PDF Report Presentation Webcast
2021-10-19 | Ascelia Pharma’s Food Effect Study with Orviglance successfully completed PDF Report Presentation Webcast
Regulatory 2021-09-21 | Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the Development of Oncoral in Combination with LONSURF® PDF Report Presentation Webcast
Regulatory 2021-08-19 | Quarterly Report Q2 2021: Preparing Oncoral for the next level PDF Report Presentation Webcast
Regulatory 2021-08-18 | Covid-19 extends recruitment period of SPARKLE study PDF Report Presentation Webcast
2021-08-13 | Abstract for Orviglance comparison study to gadolinium accepted at the world’s largest radiology conference RSNA PDF Report Presentation Webcast
2021-08-10 | Ascelia Pharma receives conditional FDA acceptance for brand name Orviglance PDF Report Presentation Webcast
Regulatory 2021-05-12 | Quarterly Report Q1 2021: US office opened in preparation of launch PDF Report Presentation Webcast
Regulatory 2021-05-05 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2021 PDF Report Presentation Webcast
Regulatory 2021-04-30 | Number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2021-04-15 | Ascelia Pharma AB publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm PDF Report Presentation Webcast
Regulatory 2021-04-13 | Bulletin from the extraordinary general meeting in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2021-04-09 | Issue and repurchase of series C shares for share saving program PDF Report Presentation Webcast
Regulatory 2021-03-31 | NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB PDF Report Presentation Webcast
Regulatory 2021-03-31 | Number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2021-03-30 | Ascelia Pharma publishes Annual Report for 2020 PDF Report Presentation Webcast
Regulatory 2021-03-17 | Notice of extraordinary general meeting in Ascelia Pharma PDF Report Presentation Webcast
Regulatory 2021-03-17 | Ascelia Pharma has carried out a directed new share issue raising SEK 200 million PDF Report Presentation Webcast